Potential Accumulation Stage...Could be big upside coming here in the future as we may currently be in some type of accumulation phase.
Next report date
Report period
H1 2024
EPS estimate
−0.01USD
Revenue estimate
16.10 MUSD
−0.0711USD
−16.69 MUSD
22.75 MUSD
141.66 M
About NEXT SCIENCE LIMITED
Sector
Industry
CEO
Harry Thomas Hall
Website
Headquarters
Sydney
Founded
2017
ISIN
AU0000041329
FIGI
BBG00P53P5G6
Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. It operates through the North America, Australia and New Zealand geographical segments. The company was founded by Matthew Myntti on October 20, 2017 and is headquartered in Sydney, Australia.
NXS | weekly upside potentially beginnighey traders,
On the weekly we have an abc. with the current move being one that looks like a contracting flat. I'm in. looking to hold for break of TL and continuation upwards.
trade safe,
MIC
Wait & watch -shows potentialAn OZ medtech co focusing on the dev of its technology to reduce the impact of biofilm-based infections in humans. The price dropped to the 88.6% fib level from its peak of $4.73. It has broken out of the LT trendline. An up move with a close above $2.70 will be interesting.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NXSCF is 0.2261 USD — it has increased by 0.49% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange NEXT SCIENCE LTD. stocks are traded under the ticker NXSCF.
NEXT SCIENCE LTD. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
NXSCF stock is 0.49% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is NEXT SCIENCE LTD. there?
NXSCF earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.02 USD resulting in a −122.78% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about NEXT SCIENCE LTD. earnings.
NEXT SCIENCE LTD. revenue for the last quarter amounts to 10.11 M USD despite the estimated figure of 10.00 M USD. In the next quarter revenue is expected to reach 12.10 M USD.
Yes, you can track NEXT SCIENCE LTD. financials in yearly and quarterly reports right on TradingView.
NXSCF stock has fallen by 9.56% compared to the previous week, the month change is a 7.71% fall, over the last year NEXT SCIENCE LTD. has showed a 53.04% decrease.
NXSCF net income for the last quarter is −7.99 M USD, while the quarter before that showed −8.49 M USD of net income which accounts for 5.90% change. Track more NEXT SCIENCE LTD. financial stats to get the full picture.
Today NEXT SCIENCE LTD. has the market capitalization of 59.90 M, it has increased by 12.69% over the last week.
No, NXSCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NXSCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXT SCIENCE LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEXT SCIENCE LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEXT SCIENCE LTD. stock shows the sell signal. See more of NEXT SCIENCE LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NEXT SCIENCE LTD. future price: according to them, NXSCF price has a max estimate of 0.26 USD and a min estimate of 0.22 USD. Read a more detailed NEXT SCIENCE LTD. forecast: see what analysts think of NEXT SCIENCE LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEXT SCIENCE LTD. EBITDA is −15.28 M USD, and current EBITDA margin is −67.24%. See more stats in NEXT SCIENCE LTD. financial statements.